Keenova Therapeutics plc Operating Cash Flow
Keenova Therapeutics plc reported Operating Cash Flow of $126.40 million for the 9-month period ending 2025-09-26, per its 10-Q filed 2025-11-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-10
- Keenova Therapeutics plc net cash provided by (used in) operating activities for the quarter ending 2025-09-26 was -$35.30M, a 125.45% decline year-over-year.
- Keenova Therapeutics plc net cash provided by (used in) operating activities for the quarter ending 2025-06-27 was $95.40M, a 205.77% increase year-over-year.
- Keenova Therapeutics plc net cash provided by (used in) operating activities for the quarter ending 2025-03-28 was $66.30M, a 319.62% increase year-over-year.
- Keenova Therapeutics plc net cash provided by (used in) operating activities for the quarter ending 2024-12-27 was -$25.00M.
- Keenova Therapeutics plc net cash provided by (used in) operating activities for fiscal 2024 was $160.70M.
- Keenova Therapeutics plc net cash provided by (used in) operating activities for fiscal 2021 was $455.40M, a 8.72% decline from fiscal 2020.
- Keenova Therapeutics plc net cash provided by (used in) operating activities for fiscal 2020 was $498.90M, a 32.84% decline from fiscal 2019.
- Keenova Therapeutics plc net cash provided by (used in) operating activities for fiscal 2019 was $742.90M, a 11.63% increase from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Operating Activities 0 month | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 5 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|---|
| 2025-09-26 | -$35.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $60.10M derived: sum of 2 quarters · filed 2025-11-10 | $126.40M 10-Q · filed 2025-11-10 | $101.40M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2025-06-27 | $95.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $161.70M 10-Q · filed 2025-08-06 | $136.70M derived: sum of 3 quarters · filed 2025-08-06 | $275.40M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2025-03-28 | $66.30M 10-Q · filed 2025-05-12 | $41.30M derived: sum of 2 quarters · filed 2025-05-12 | $180.00M derived: sum of 3 quarters · filed 2025-11-10 | $211.20M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-12-27 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $113.70M derived: sum of 2 quarters · filed 2025-11-10 | $144.90M derived: sum of 3 quarters · filed 2025-11-10 | $160.70M 10-K · filed 2025-03-13 | ||||
| 2024-09-27 | $138.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $169.90M derived: sum of 2 quarters · filed 2025-11-10 | $185.70M 10-Q · filed 2025-11-10 | |||||
| 2024-06-28 | $31.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $47.00M 10-Q · filed 2025-08-06 | ||||||
| 2024-03-29 | $15.80M 10-Q · filed 2025-05-12 | |||||||
| 2023-12-29 | $178.40M 10-K · filed 2025-03-13 | |||||||
| 2023-11-14 | -$412.10M 10-K · filed 2025-03-13 | |||||||
| 2023-09-29 | -$418.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$397.60M derived: sum of 2 quarters · filed 2024-11-05 | -$297.70M 10-Q · filed 2024-11-05 | -$269.90M derived: sum of 4 quarters · filed 2025-03-13 | ||||
| 2023-06-30 | $21.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $121.00M 10-Q · filed 2024-08-06 | $148.80M derived: sum of 3 quarters · filed 2025-03-13 | $168.10M derived: sum of 4 quarters · filed 2025-03-13 | ||||
| 2023-03-31 | $99.90M 10-Q · filed 2024-05-09 | $127.70M derived: sum of 2 quarters · filed 2025-03-13 | $147.00M derived: sum of 3 quarters · filed 2025-03-13 | |||||
| 2022-12-30 | $27.80M derived: 10-K 6 month − 10-Q 3 month · filed 2025-03-13 | $47.10M 10-K · filed 2025-03-13 | ||||||
| 2022-09-30 | $19.30M 10-Q · filed 2023-11-07 | |||||||
| 2022-07-01 | -$15.50M 10-Q · filed 2023-08-09 | |||||||
| 2022-06-16 | -$642.30M 10-K · filed 2025-03-13 | |||||||
| 2022-04-01 | $49.20M 10-Q · filed 2023-05-09 | $98.20M derived: sum of 2 quarters · filed 2024-03-26 | $180.60M derived: sum of 3 quarters · filed 2024-03-26 | $353.20M derived: sum of 4 quarters · filed 2024-03-26 | ||||
| 2021-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $131.40M derived: sum of 2 quarters · filed 2024-03-26 | $304.00M derived: sum of 3 quarters · filed 2024-03-26 | $455.40M 10-K · filed 2024-03-26 | ||||
| 2021-09-24 | $82.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $255.00M derived: sum of 2 quarters · filed 2022-11-08 | $406.40M 10-Q · filed 2022-11-08 | $610.60M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-06-25 | $172.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $324.00M 10-Q · filed 2022-08-11 | $528.20M derived: sum of 3 quarters · filed 2023-03-03 | $598.30M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-26 | $151.40M 10-Q · filed 2022-05-03 | $355.60M derived: sum of 2 quarters · filed 2023-03-03 | $425.70M derived: sum of 3 quarters · filed 2023-03-03 | $596.60M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-25 | $204.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $274.30M derived: sum of 2 quarters · filed 2023-03-03 | $445.20M derived: sum of 3 quarters · filed 2023-03-03 | $498.90M 10-K · filed 2023-03-03 | ||||
| 2020-09-25 | $70.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $241.00M derived: sum of 2 quarters · filed 2021-11-02 | $294.70M 10-Q · filed 2021-11-02 | $503.50M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-06-26 | $170.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $224.60M 10-Q · filed 2021-08-03 | $433.40M derived: sum of 3 quarters · filed 2022-03-15 | $500.10M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-03-27 | $53.70M 10-Q · filed 2021-05-04 | $262.50M derived: sum of 2 quarters · filed 2022-03-15 | $329.20M derived: sum of 3 quarters · filed 2022-03-15 | $632.10M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2019-12-27 | $208.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $275.50M derived: sum of 2 quarters · filed 2022-03-15 | $578.40M derived: sum of 3 quarters · filed 2022-03-15 | $742.90M 10-K · filed 2022-03-15 | ||||
| 2019-09-27 | $66.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $369.60M derived: sum of 2 quarters · filed 2020-11-03 | $534.10M 10-Q · filed 2020-11-03 | $718.50M derived: sum of 4 quarters · filed 2021-03-10 | ||||
| 2019-06-28 | $302.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $467.40M 10-Q · filed 2020-08-04 | $651.80M derived: sum of 3 quarters · filed 2021-03-10 | |||||
| 2019-03-29 | $164.50M 10-Q · filed 2020-05-06 | $348.90M derived: sum of 2 quarters · filed 2021-03-10 | ||||||
| 2018-12-28 | $184.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $665.50M 10-K · filed 2021-03-10 | ||||||
| 2018-09-28 | $481.10M 10-Q · filed 2019-11-05 | |||||||
| 2017-12-29 | $727.30M 10-K · filed 2020-02-26 |